• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE Back to Search Results
Model Number 8637-40
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Diarrhea (1811); Pain (1994); Therapeutic Effects, Unexpected (2099); Sweating (2444)
Event Date 02/28/2020
Event Type  Injury  
Manufacturer Narrative
The manufacturer¿s device registration system indicates the device system was replaced.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from a consumer and a healthcare professional (hcp) via a company representative regarding a patient receiving morphine sulfate (10 mg/ml) via an implanted pump.On (b)(6) 2020 it was reported that the patient had had insufficient therapy since the revision/replacement procedure in (b)(6) 2020.His pain was still the same as it was prior to the original implant and he had been experiencing diarrhea and frequent sweating since prior to the revision procedure in february.There were no external factors that contributed to the issue.On (b)(6) 2020, a dye study was done and there was no device issue found.The catheter was intact with no issues.A perfect myelogram was formed by the dye in the intrathecal space according to the physician.The physician then increased the patient¿s daily dose by 20% (from 1.440 mg/day to 1.726 mg/day) and the patient¿s symptoms, according to the patient, had resolved as of (b)(6) 2020.The cause of the symptoms was not determined.Additional information was received, and it was reported that the patient had never gotten good therapy since his revision back in (b)(6) 2020, so he was taken to the or (operating room) on 02-oct-2020.At the time of the report the patient was still in the or and they had done a dye study and it was negative and there were no stalls in the logs and no volume discrepancies had been seen.
 
Manufacturer Narrative
Continuation of d11: product id 8780 lot# serial# (b)(6) implanted: (b)(6)2018 explanted: (b)(6)2020 product type catheter pro duct id 8784 lot# serial# (b)(6) implanted: (b)(6)2020 explanted: (b)(6)2020 product type catheter.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from the healthcare provider via the device manufacturer representative indicated that the device was functioning perfectly normal and no issues were found.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCHROMED II
Type of Device
PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
MDR Report Key10641820
MDR Text Key210188199
Report Number3004209178-2020-17396
Device Sequence Number1
Product Code LKK
UDI-Device Identifier00643169630512
UDI-Public00643169630512
Combination Product (y/n)N
PMA/PMN Number
P860004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Type of Report Initial,Followup
Report Date 10/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/28/2021
Device Model Number8637-40
Device Catalogue Number8637-40
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/02/2020
Initial Date FDA Received10/07/2020
Supplement Dates Manufacturer Received10/12/2020
Supplement Dates FDA Received10/14/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
"SEE H10...."
Patient Outcome(s) Required Intervention;
Patient Age60 YR
-
-